The TPP Is Dead. Long Live Free Trade.

With the Trans-Pacific Partnership multinational trade deal seemingly dead in the water, attention is now turning to potential alternative trade agreements in the Asia-Pacific region. But how might these play out for the global pharma industry?

International Flags Blowing In Wind_1200x675

US President-Elect Donald Trump has declared his intention to issue a formal notification of withdrawal from the Trans-Pacific Partnership (TPP) the day he takes office on Jan. 20, labeling the still non-ratified multinational trade agreement "a potential disaster for our country.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal & IP

More from Pink Sheet